Daiichi Sankyo to offset sales-related carbon footprint
This article was originally published in Scrip
Executive Summary
In apparently the first such move by a Japanese pharmaceutical company in Japan, Daiichi Sankyois to purchase carbon credits to help offset exhaust emissions from its fleet of sales vehicles in Japan. The credits will be acquired through a route recognised by the Kyoto Protocol on global warming in a certified greenhouse gas reduction project in Ulsan, South Korea, to help offset sales-related company carbon dioxide emissions of 9,000 tonnes per annum. Daiichi Sankyo noted that it already employs fuel-efficient driving methods and low emission and hybrid vehicles in its sales efforts, which also make use of public transport.